Chemed Shares Gain on Full-Year Outlook

Dow Jones

Apr 24

By Elias Schisgall

Shares of Chemed rose after the company lifted its full-year guidance following revenue growth in the company's hospice business.

Shares were up 10% to $421.25 in after-hours trading Thursday. The stock closed up 2.6% at $382.97, down 10% this year.

The company, which owns a hospice care provider and a plumbing and drain cleaning business, said it now expects full-year adjusted earnings between $24.00 and $24.75 a share, up from a previous range of $23.25 to $24.25 a share.

Analysts polled by FactSet are expecting $23.88 a share.

The outlook lift was driven by the improved performance of the company's hospice business, Vitas, as well as Chemed's share repurchases in the first quarter, the company said.

Chemed on Thursday reported a profit of $66.3 million, or $4.84 a share, down from its profit of $71.8 million, or $4.86 a share, a year earlier.

Stripping out certain one-time items, the company logged adjusted earnings of $5.65 a share. Analysts were expecting $5.30 a share.

Sales and service revenues rose to $657.5 million from $646.9 million a year prior. Analysts were anticipating $649.8 million.

Vitas revenue rose 3.1% to $420 million. Roto-Rooter, the company's plumbing and drain-cleaning business, posted revenue of $237.5 million, down 0.9% year over year.

Write to Elias Schisgall at elias.schisgall@wsj.com

(END) Dow Jones Newswires

April 23, 2026 18:07 ET (22:07 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/2629218869"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2629218869\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2629218869?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-24 06:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2629218869","market":"other","top_or_hot":-1,"title":"Chemed Shares Gain on Full-Year Outlook","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Chemed rose after the company lifted its full-year guidance following revenue growth in the company's hospice business. \n</p>\n<p>\n  Shares were up 10% to $421.25 in after-hours trading Thursday. The stock closed up 2.6% at $382.97, down 10% this year. \n</p>\n<p>\n  The company, which owns a hospice care provider and a plumbing and drain cleaning business, said it now expects full-year adjusted earnings between $24.00 and $24.75 a share, up from a previous range of $23.25 to $24.25 a share. \n</p>\n<p>\n  Analysts polled by FactSet are expecting $23.88 a share. \n</p>\n<p>\n  The outlook lift was driven by the improved performance of the company's hospice business, Vitas, as well as Chemed's share repurchases in the first quarter, the company said. \n</p>\n<p>\n  Chemed on Thursday reported a profit of $66.3 million, or $4.84 a share, down from its profit of $71.8 million, or $4.86 a share, a year earlier. \n</p>\n<p>\n  Stripping out certain one-time items, the company logged adjusted earnings of $5.65 a share. Analysts were expecting $5.30 a share. \n</p>\n<p>\n  Sales and service revenues rose to $657.5 million from $646.9 million a year prior. Analysts were anticipating $649.8 million. \n</p>\n<p>\n  Vitas revenue rose 3.1% to $420 million. Roto-Rooter, the company's plumbing and drain-cleaning business, posted revenue of $237.5 million, down 0.9% year over year. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 23, 2026 18:07 ET (22:07 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chemed Shares Gain on Full-Year Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChemed Shares Gain on Full-Year Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-04-24 06:07</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Chemed rose after the company lifted its full-year guidance following revenue growth in the company's hospice business. \n</p>\n<p>\n  Shares were up 10% to $421.25 in after-hours trading Thursday. The stock closed up 2.6% at $382.97, down 10% this year. \n</p>\n<p>\n  The company, which owns a hospice care provider and a plumbing and drain cleaning business, said it now expects full-year adjusted earnings between $24.00 and $24.75 a share, up from a previous range of $23.25 to $24.25 a share. \n</p>\n<p>\n  Analysts polled by FactSet are expecting $23.88 a share. \n</p>\n<p>\n  The outlook lift was driven by the improved performance of the company's hospice business, Vitas, as well as Chemed's share repurchases in the first quarter, the company said. \n</p>\n<p>\n  Chemed on Thursday reported a profit of $66.3 million, or $4.84 a share, down from its profit of $71.8 million, or $4.86 a share, a year earlier. \n</p>\n<p>\n  Stripping out certain one-time items, the company logged adjusted earnings of $5.65 a share. Analysts were expecting $5.30 a share. \n</p>\n<p>\n  Sales and service revenues rose to $657.5 million from $646.9 million a year prior. Analysts were anticipating $649.8 million. \n</p>\n<p>\n  Vitas revenue rose 3.1% to $420 million. Roto-Rooter, the company's plumbing and drain-cleaning business, posted revenue of $237.5 million, down 0.9% year over year. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 23, 2026 18:07 ET (22:07 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1596574779.USD","symbol_name":"BNP PARIBAS AQUA \"C\" (USDHDG) ACC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2629218869","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2629218869","pubTimestamp":1776982020,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Chemed rose after the company lifted its full-year guidance following revenue growth in the company's hospice business.Shares were up 10% to $421.25 in after-hours trading Thursday. The stock closed up 2.6% at $382.97, down 10% this year.The company, which owns a hospice care provider and a plumbing and drain cleaning business, said it now expects full-year adjusted earnings between $24.00 and $24.75 a share, up from a previous range of $23.25 to $24.25 a share.Analysts polled by FactSet are expecting $23.88 a share.The outlook lift was driven by the improved performance of the company's hospice business, Vitas, as well as Chemed's share repurchases in the first quarter, the company said.Chemed on Thursday reported a profit of $66.3 million, or $4.84 a share, down from its profit of $71.8 million, or $4.86 a share, a year earlier.Sales and service revenues rose to $657.5 million from $646.9 million a year prior. Analysts were anticipating $649.8 million.Vitas revenue rose 3.1","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1596574779.USD":"BNP PARIBAS AQUA \"C\" (USDHDG) ACC","LU2413666004.HKD":"BNP PARIBAS AQUA \"CRH\" (HKDHDG) INC","LU1165135440.EUR":"BNP Paribas Aqua Classic Cap EUR","CHE":"Chemed Corp","BK4196":"保健护理服务","IE00B64QTZ34.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) ACC","LU1620156130.USD":"BNP PARIBAS AQUA \"C\" (USD) ACC","LU2413665964.HKD":"BNP PARIBAS AQUA \"C\" (HKD) ACC","LU1543694498.USD":"法巴水资源基金RH MD Dis","IE00BLDYK493.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) INC","LU1721427968.SGD":"BNP PARIBAS AQUA \"CRH\" (SGDHDG) INC","LU1620156213.USD":"BNP PARIBAS AQUA \"C\" (USD) INC"},"translate_title":"Chemed股价因全年前景而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CHE":1.5},"content_text":"By Elias Schisgall \n\n\n \n\n\n  Shares of Chemed rose after the company lifted its full-year guidance following revenue growth in the company's hospice business. \n\n\n  Shares were up 10% to $421.25 in after-hours trading Thursday. The stock closed up 2.6% at $382.97, down 10% this year. \n\n\n  The company, which owns a hospice care provider and a plumbing and drain cleaning business, said it now expects full-year adjusted earnings between $24.00 and $24.75 a share, up from a previous range of $23.25 to $24.25 a share. \n\n\n  Analysts polled by FactSet are expecting $23.88 a share. \n\n\n  The outlook lift was driven by the improved performance of the company's hospice business, Vitas, as well as Chemed's share repurchases in the first quarter, the company said. \n\n\n  Chemed on Thursday reported a profit of $66.3 million, or $4.84 a share, down from its profit of $71.8 million, or $4.86 a share, a year earlier. \n\n\n  Stripping out certain one-time items, the company logged adjusted earnings of $5.65 a share. Analysts were expecting $5.30 a share. \n\n\n  Sales and service revenues rose to $657.5 million from $646.9 million a year prior. Analysts were anticipating $649.8 million. \n\n\n  Vitas revenue rose 3.1% to $420 million. Roto-Rooter, the company's plumbing and drain-cleaning business, posted revenue of $237.5 million, down 0.9% year over year. \n\n\n \n\n\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 23, 2026 18:07 ET (22:07 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}